News + Filings Transactions
|
DOVEY BRIAN H
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 11/11/2019 | REVA Medical, Inc. | RVA.AX | Sale | Common Stock | 15.5k | $0.00 | $1.6 | | 11/11/2019 |
| 11/11/2019 | REVA Medical, Inc. | RVA.AX | Sale | Common Stock | 15.5k | $0.00 | $1.6 | By Domain Associates, LLC | 11/11/2019 |
| 11/11/2019 | REVA Medical, Inc. | RVA.AX | Sale | Common Stock | 3.6M | $0.00 | $0 | By Domain Partners V, L.P. | 11/11/2019 |
| 11/11/2019 | REVA Medical, Inc. | RVA.AX | Sale | Common Stock | 85.2k | $0.00 | $0 | By DP V Associates, L.P. | 11/11/2019 |
| 06/29/2018 | REVA Medical, Inc. | RVA.AX | Other (disposition) | Common Stock | 3k | $0.00 | $0 | | 06/29/2018 |
| 06/29/2018 | REVA Medical, Inc. | RVA.AX | Other (acquisition) | Common Stock | 3k | $0.00 | $0 | By Domain Associates, LLC | 06/29/2018 |
| 05/16/2018 | REVA Medical, Inc. | RVA.AX | Grant | Stock Option (Right to Buy) | 25k | $1.96 | $49k | | 05/16/2018 |
| 07/25/2017 | REVA Medical, Inc. | RVA.AX | Other (disposition) | Common Stock | 5k | $0.00 | $0 | | 07/25/2017 |
| 07/25/2017 | REVA Medical, Inc. | RVA.AX | Other (acquisition) | Common Stock | 5k | $0.00 | $0 | By Domain Associates, LLC | 07/25/2017 |
| 07/14/2017 | Orexigen Therapeutics, Inc. | OREXQ | Grant | Stock Option (Right to Buy) | 5k | $2.88 | $14.4k | | 07/14/2017 |
| 07/09/2017 | REVA Medical, Inc. | RVA.AX | Grant | Common Stock | 6k | $0.00 | $0 | | 07/09/2017 |
| 07/09/2017 | REVA Medical, Inc. | RVA.AX | Grant | Stock Option (Right to Buy) | 10.5k | $6.45 | $67.7k | | 07/09/2017 |
| 08/01/2016 | REVA Medical, Inc. | RVA.AX | Other (disposition) | Common Stock | 7.5k | $0.00 | $0 | | 08/01/2016 |
| 08/01/2016 | REVA Medical, Inc. | RVA.AX | Other (acquisition) | Common Stock | 7.5k | $0.00 | $0 | By Domain Associates, LLC | 08/01/2016 |
| 05/25/2016 | REVA Medical, Inc. | RVA.AX | Grant | Common Stock | 10k | $0.00 | $0 | | 05/25/2016 |
| 05/25/2016 | REVA Medical, Inc. | RVA.AX | Grant | Stock Option (Right to Buy) | 11.8k | $8.30 | $97.9k | | 05/25/2016 |
| 06/09/2015 | Orexigen Therapeutics, Inc. | OREXQ | Grant | Stock Option (Right to Buy) | 50k | $4.63 | $231.5k | | 06/09/2015 |
| 05/28/2015 | OTONOMY, INC. | OTIC | Other (disposition) | Common Stock | 250k | $0.00 | $0 | By Domain Partners VIII, L.P. | 05/28/2015 |
| 05/28/2015 | OTONOMY, INC. | OTIC | Other (acquisition) | Common Stock | 32.7k | $0.00 | $0 | By One Palmer Square Associates VIII, LLC | 05/28/2015 |
| 05/27/2015 | REVA Medical, Inc. | RVA.AX | Grant | Common Stock | 15k | $0.00 | $0 | | 05/27/2015 |
| 11/04/2013 | VERACYTE, INC. | VCYT | Conversion | Common Stock | 3.1M | $0.00 | $0 | By Domain Partners VIII, L.P. | 11/04/2013 |
| 11/04/2013 | VERACYTE, INC. | VCYT | Conversion | Common Stock | 22.7k | $0.00 | $0 | By DP VIII Associates, L.P. | 11/04/2013 |
| 11/04/2013 | VERACYTE, INC. | VCYT | Conversion | Series B Preferred Stock | 2.4M | $0.00 | $0 | By Domain Partners VIII, L.P. | 11/04/2013 |
| 11/04/2013 | VERACYTE, INC. | VCYT | Conversion | Series B Preferred Stock | 17.7k | $0.00 | $0 | By DP VIII Associates, L.P. | 11/04/2013 |
| 11/04/2013 | VERACYTE, INC. | VCYT | Conversion | Series C Preferred Stock | 681k | $0.00 | $0 | By Domain Partners VIII, L.P. | 11/04/2013 |
| 11/04/2013 | VERACYTE, INC. | VCYT | Conversion | Series C Preferred Stock | 5.1k | $0.00 | $0 | By DP VIII Associates, L.P. | 11/04/2013 |
| 09/30/2013 | Evoke Pharma Inc | EVOK | Conversion | Series A Preferred Stock | 19k | $0.00 | $0 | By DP VII Associates, L.P. | 09/30/2013 |
| 09/30/2013 | Evoke Pharma Inc | EVOK | Conversion | Series A Preferred Stock | 1.1M | $0.00 | $0 | By Domain Partners VII, L.P. | 09/30/2013 |
| 09/30/2013 | Evoke Pharma Inc | EVOK | Conversion | Common Stock | 19k | $0.00 | $0 | By DP VII Associates, L.P. | 09/30/2013 |
| 09/30/2013 | Evoke Pharma Inc | EVOK | Conversion | Common Stock | 1.1M | $0.00 | $0 | By Domain Partners VII, L.P. | 09/30/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Common Stock | 7.4k | $0.00 | $0 | By DP VI Associates, L.P. | 08/27/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Series D Preferred Stock | 894.1k | $0.00 | $0 | By Domain Partners VI, L.P. | 08/27/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Series E Preferred Stock | 225.9k | $0.00 | $0 | By Domain Partners VI, L.P. | 08/27/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Series B Preferred Stock | 4.2k | $0.00 | $0 | By DP VI Associates, L.P. | 08/27/2013 |
| 08/27/2013 | Tobira Therapeutics, Inc. | TBRA | Conversion | Series C Preferred Stock | 2.9k | $0.00 | $0 | By DP VI Associates, L.P. | 08/27/2013 |
|
|